- Record: found
- Abstract: not found
- Article: not found
Impact of soluble HER2 levels (sHER2) on disease-free survival for patients receiving chemotherapy ± Trastuzumab in early-stage HER2-positive breast cancer from the NCCTG adjuvant trial N9831
Read this article at
ScienceOpen
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.